JP2024109660A5 - - Google Patents

Download PDF

Info

Publication number
JP2024109660A5
JP2024109660A5 JP2024076686A JP2024076686A JP2024109660A5 JP 2024109660 A5 JP2024109660 A5 JP 2024109660A5 JP 2024076686 A JP2024076686 A JP 2024076686A JP 2024076686 A JP2024076686 A JP 2024076686A JP 2024109660 A5 JP2024109660 A5 JP 2024109660A5
Authority
JP
Japan
Prior art keywords
site
pam
pam site
spacer
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024076686A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024109660A (ja
JP7761294B2 (ja
Filing date
Publication date
Priority claimed from JP2021544682A external-priority patent/JP7518549B2/ja
Application filed filed Critical
Publication of JP2024109660A publication Critical patent/JP2024109660A/ja
Publication of JP2024109660A5 publication Critical patent/JP2024109660A5/ja
Priority to JP2025170065A priority Critical patent/JP2026012727A/ja
Application granted granted Critical
Publication of JP7761294B2 publication Critical patent/JP7761294B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024076686A 2019-02-02 2024-05-09 遺伝子編集における非意図的な変異の阻害 Active JP7761294B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025170065A JP2026012727A (ja) 2019-02-02 2025-10-08 遺伝子編集における非意図的な変異の阻害

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CNPCT/CN2019/074577 2019-02-02
CN2019074577 2019-02-02
JP2021544682A JP7518549B2 (ja) 2019-02-02 2020-02-03 遺伝子編集における非意図的な変異の阻害
PCT/CN2020/074218 WO2020156575A1 (en) 2019-02-02 2020-02-03 Inhibition of unintended mutations in gene editing

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021544682A Division JP7518549B2 (ja) 2019-02-02 2020-02-03 遺伝子編集における非意図的な変異の阻害

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025170065A Division JP2026012727A (ja) 2019-02-02 2025-10-08 遺伝子編集における非意図的な変異の阻害

Publications (3)

Publication Number Publication Date
JP2024109660A JP2024109660A (ja) 2024-08-14
JP2024109660A5 true JP2024109660A5 (cg-RX-API-DMAC7.html) 2024-09-12
JP7761294B2 JP7761294B2 (ja) 2025-10-28

Family

ID=71841894

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021544682A Active JP7518549B2 (ja) 2019-02-02 2020-02-03 遺伝子編集における非意図的な変異の阻害
JP2024076686A Active JP7761294B2 (ja) 2019-02-02 2024-05-09 遺伝子編集における非意図的な変異の阻害
JP2025170065A Pending JP2026012727A (ja) 2019-02-02 2025-10-08 遺伝子編集における非意図的な変異の阻害

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021544682A Active JP7518549B2 (ja) 2019-02-02 2020-02-03 遺伝子編集における非意図的な変異の阻害

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025170065A Pending JP2026012727A (ja) 2019-02-02 2025-10-08 遺伝子編集における非意図的な変異の阻害

Country Status (12)

Country Link
US (3) US11384353B2 (cg-RX-API-DMAC7.html)
EP (1) EP3918083A4 (cg-RX-API-DMAC7.html)
JP (3) JP7518549B2 (cg-RX-API-DMAC7.html)
KR (2) KR102964723B1 (cg-RX-API-DMAC7.html)
CN (4) CN116656676A (cg-RX-API-DMAC7.html)
AU (3) AU2020214090B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021015092A2 (cg-RX-API-DMAC7.html)
CA (1) CA3128283A1 (cg-RX-API-DMAC7.html)
IL (1) IL285194A (cg-RX-API-DMAC7.html)
SG (1) SG11202108303SA (cg-RX-API-DMAC7.html)
WO (1) WO2020156575A1 (cg-RX-API-DMAC7.html)
ZA (2) ZA202105895B (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4244369A4 (en) * 2020-11-12 2024-10-16 Shanghaitech University GENOME EDITING OF IMPROVED EFFICIENCY AND ACCURACY
CN112575014B (zh) * 2020-12-11 2022-04-01 安徽省农业科学院水稻研究所 一种碱基编辑器SpCas9-LjCDAL1及其构建和应用
CN115161316B (zh) * 2021-04-02 2025-12-23 上海科技大学 一种引导编辑工具、融合rna及其用途
EP4314308A4 (en) * 2021-04-02 2026-05-20 Univ Shanghai Technology GENE THERAPY FOR THE TREATMENT OF BETA-HEMOGLOBINOPATHIES
EP4330389A4 (en) * 2021-04-30 2025-04-30 Alnylam Pharmaceuticals, Inc. RISC REORIENTATION FOR RNA EDITING
US12123006B2 (en) * 2021-05-18 2024-10-22 Shanghaitech University Base editing tool and use thereof
WO2023283092A1 (en) * 2021-07-06 2023-01-12 Prime Medicine, Inc. Compositions and methods for efficient genome editing
US20250019724A1 (en) * 2021-11-18 2025-01-16 Correctsequence Therapeutics Regeneration of surface antigen-negative cells
KR102667508B1 (ko) * 2022-02-08 2024-06-11 주식회사 툴젠 프라임 에디팅 시스템을 이용한 게놈 편집의 과정에서 발생 가능한 오프 타겟을 예측하는 방법
WO2023155901A1 (en) * 2022-02-17 2023-08-24 Correctsequence Therapeutics Mutant cytidine deaminases with improved editing precision
CN119998446A (zh) 2022-06-07 2025-05-13 斯克里贝治疗公司 用于靶向pcsk9的组合物和方法
WO2024012435A1 (en) 2022-07-11 2024-01-18 CorrectSequence Therapeutics Co., Ltd Gene editing systems and methods for treating hereditary angioedema
WO2024042489A1 (en) 2022-08-25 2024-02-29 LifeEDIT Therapeutics, Inc. Chemical modification of guide rnas with locked nucleic acid for rna guided nuclease-mediated gene editing
EP4608979A1 (en) * 2022-10-28 2025-09-03 CorrectSequence Therapeutics (Shanghai) Co., Ltd Gene editing systems and methods for reducing immunogenicity and graft versus host response
IL320573A (en) 2022-11-04 2025-07-01 Life Edit Therapeutics Inc Developed adenine deaminases and RNA-guided nuclease fusion proteins with internal insertion sites and methods of use
WO2024109745A1 (en) * 2022-11-21 2024-05-30 CorrectSequence Therapeutics Co., Ltd Gene editing systems and methods for treating hbv infection
EP4622662A1 (en) * 2022-11-23 2025-10-01 Amber Bio Inc. Gene-modifying endonucleases
WO2024127369A1 (en) 2022-12-16 2024-06-20 LifeEDIT Therapeutics, Inc. Guide rnas that target foxp3 gene and methods of use
WO2024127370A1 (en) 2022-12-16 2024-06-20 LifeEDIT Therapeutics, Inc. Guide rnas that target trac gene and methods of use
CN116286740A (zh) * 2023-02-24 2023-06-23 四川大学华西医院 碱基编辑器和引导编辑器及构建与应用
WO2024178397A2 (en) 2023-02-24 2024-08-29 Elevatebio Technologies, Inc. Modified immune effector cells and methods of use
CN121100181A (zh) * 2023-05-26 2025-12-09 正序(上海)生物医药科技有限公司 基因编辑系统及其用途
EP4750890A2 (en) 2023-07-27 2026-06-03 Life Edit Therapeutics, Inc. Rna-guided nucleases and active fragments and variants thereof and methods of use
EP4780862A1 (en) * 2023-09-21 2026-07-29 Shanghaitech University Rna editing systems of high efficiency and specificity
WO2025081042A1 (en) 2023-10-12 2025-04-17 Renagade Therapeutics Management Inc. Nickase-retron template-based precision editing system and methods of use
CN122422501A (zh) 2023-10-18 2026-07-17 生命编辑治疗股份有限公司 Rna引导的核酸酶及其活性片段和变体以及使用方法
CN117092084B (zh) * 2023-10-20 2024-01-12 浙江迪福润丝生物科技有限公司 Wnv蛋白酶抑制剂的筛选方法和抑制效果评价方法
WO2025140399A1 (en) * 2023-12-26 2025-07-03 Correctsequence Therapeutics (Shanghai) Co., Ltd Gene editing systems and methods for treating cardiovascular disease
WO2025174908A1 (en) 2024-02-12 2025-08-21 Life Edit Therapeutics, Inc. Novel rna-guided nucleases and proteins for polymerase editing
WO2025185623A1 (en) * 2024-03-04 2025-09-12 Shanghaitech University Virus-like particles for gene editing
TW202617985A (zh) 2024-06-25 2026-05-01 美商生命編輯治療學公司 新穎反轉錄酶及其用途
WO2026026929A1 (en) * 2024-07-31 2026-02-05 Correctsequence Therapeutics (Shanghai) Co., Ltd Gene editing systems and methods for treating obesity and metabolic dysfunction and associated diseases
CN118995709B (zh) * 2024-08-23 2026-08-07 东北农业大学 一种提高基因编辑效率的重组型pegRNA及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6445314A (en) 1987-04-16 1989-02-17 Res Corp Technologies Inc Antitumoral
US8288094B2 (en) 2008-04-09 2012-10-16 Institut Pasteur APOBEC3 mediated DNA editing
US8399219B2 (en) * 2009-02-23 2013-03-19 Cytomx Therapeutics, Inc. Protease activatable interferon alpha proprotein
CN111206032B (zh) * 2013-12-12 2024-07-19 布罗德研究所有限公司 用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用
WO2015089473A1 (en) * 2013-12-12 2015-06-18 The Broad Institute Inc. Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation
US20150166984A1 (en) * 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
CN105886498A (zh) * 2015-05-13 2016-08-24 沈志荣 CRISPR-Cas9特异性敲除人PCSK9基因的方法以及用于特异性靶向PCSK9基因的sgRNA
WO2017070632A2 (en) * 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
EP3445853A1 (en) * 2016-04-19 2019-02-27 The Broad Institute, Inc. Cpf1 complexes with reduced indel activity
WO2018052247A1 (ko) * 2016-09-13 2018-03-22 주식회사 툴젠 시토신 디아미나제에 의한 dna에서의 염기 교정 확인 방법
US11192929B2 (en) * 2016-12-08 2021-12-07 Regents Of The University Of Minnesota Site-specific DNA base editing using modified APOBEC enzymes
KR102569848B1 (ko) * 2016-12-23 2023-08-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Pcsk9의 유전자 편집
CN108342387B (zh) 2017-01-24 2021-09-24 谭旭 Pcsk9抑制剂类降血脂药的递送系统和生物制剂
JP7277052B2 (ja) * 2017-02-22 2023-05-18 クリスパー セラピューティクス アーゲー プロタンパク質転換酵素サブチリシン/ケキシン9型(pcsk9)関連障害の処置のための組成物および方法
IL306092A (en) * 2017-03-23 2023-11-01 Harvard College Nucleic base editors that include nucleic acid programmable DNA binding proteins
WO2018208998A1 (en) * 2017-05-10 2018-11-15 The Regents Of The University Of California Directed editing of cellular rna via nuclear delivery of crispr/cas9
CA3063733A1 (en) * 2017-05-25 2018-11-29 The General Hospital Corporation Base editors with improved precision and specificity
CN109136272A (zh) 2017-06-15 2019-01-04 中山大学 用于特异性修复人hbb基因突变的碱基编辑系统、方法、试剂盒及其在人生殖系中的应用
SG11201912024RA (en) * 2017-07-31 2020-02-27 Sigma Aldrich Co Llc Synthetic guide rna for crispr/cas activator systems
CN109021111B (zh) * 2018-02-23 2021-12-07 上海科技大学 一种基因碱基编辑器

Similar Documents

Publication Publication Date Title
Van Dijk et al. Library preparation methods for next-generation sequencing: tone down the bias
EP3192869B1 (en) Isolated oligonucleotide and use thereof in nucleic acid sequencing
JP6894501B2 (ja) 等温核酸自己増幅法
US20100035249A1 (en) Rna sequencing and analysis using solid support
JP2002519038A5 (cg-RX-API-DMAC7.html)
DK1314783T3 (da) Nukleinsyrelinkere og deres anvendelse i gensyntese
JP2025084823A (ja) リプログラミングされたtracrRNAを用いたRNA検出及び転写依存性編集
JP2022547949A (ja) シーケンシングのためのrna試料を調製する方法およびそのキット
JP2023549125A5 (cg-RX-API-DMAC7.html)
CN108251503A (zh) 一种快速构建链特异性rna高通量测序文库的方法
CN114293264B (zh) 酶法靶序列随机sgRNA文库的制备方法
JP2006506953A5 (cg-RX-API-DMAC7.html)
US20250066752A1 (en) Crispr-based programmable rna editing
JP7550761B2 (ja) 一本鎖dnaの合成方法
CN116590322A (zh) 一种crispr-mcpn载体及其构建方法、应用
US8470537B2 (en) Sequential addition of short DNA oligos in DNA-polymerase-based synthesis reactions
WO2021192596A1 (ja) 連結dnaの製造方法及びそれに用いるためのベクターの組み合わせ
US11572554B2 (en) Target irrelevant guide RNA for CRISPR
JP2023538537A (ja) 核酸の標的化除去のための方法
JP4509307B2 (ja) RecAタンパク質を用いてライブラリーを加工する方法
US20030180781A1 (en) Constructing very long DNA sequences from synthetic DNA molecules
US20250354177A1 (en) System and methods for duplicating target fragments
EP1295942B1 (en) Method for processing a library using ligation inhibition
US20030104467A1 (en) Process for preparation of full-length cDNA and anchor used for the same
JP2023545403A5 (cg-RX-API-DMAC7.html)